Kokorin V.A., Gonzalez-Franco A., Cittadini A., Kalejs O., Larina V.N., Marra A.M., Medrano F.J., Monhart Z., Morbidoni L., Pimenta J., Lesniak W.
Acute heart failure – An EFIM guideline critical appraisal and adaptation for internists
|
№4 / 2024
|
Kokorin V.A., Larina V.N., Lunev D.I., Suvorova N.A.
Based on materials of community-acquired pneumonia – an European Federation of Internal Medicine guideline critical appraisal adaptation for internists: Important answers to difficult questions
|
№6 / 2023
|
Nikolaev N.A.
Should the application of clinical guidelines be mandatory or recommendatory?
|
№4 / 2023
|
Malyavin A.G., Martynov A.I., Gorelov A.V., Lioznov D.A., Esaulenko E.V., Pshenichnaya N.Yu., Bolieva L.Z, Gurov A.V., Karneeva O.V., Babak S.L.
Resolution of the Expert Council on the use of herbal medicines for respiratory infections
|
№2 / 2023
|
Alekseeva L.I., Lila A.M., Taskina E.A., Mazurov V.I., Martynov A.I., Barantsevich E.R., Vasylkin A.K., Gaydukova I.Z., Karateev A.E., Kashevarova N.G., Kochish A.Yu., Strebkova E.A., Trofimov E.A., Chichasova N.V., Shostak N.A.
Clinical guidelines (project) for the diagnostics and treatment of primary osteoarthritis for primary care specialists (general practitioners, therapists)
|
№1 / 2023
|
Zaitsev A.A., Leshchenko I.V., Malyavin A.G.
Acute bronchitis – project of clinical guidelines
|
№5 / 2022
|
Becattini С., Kokorin V.A., Lesniak W., Marin-Leon I., Medrano F.J., Morbidoni L., Marra A.M., Biskup E., Riera-Mestre A., Dicker D.
Pulmonary embolism – An EFIM guideline critical appraisal and adaptation for practicing clinicians
|
№1 / 2022
|
Vizel A.A., Vizel I.Y.
Sarkoidosis: basic provisions of the project of federal clinical recommendations
|
№5 / 2019
|
Kovaleva M.Yu., Kolieva G.L., Sukhorukikh O.A.
Clinical guidelines: history of creation and development in the Russian Federation and abroad
|
№5 / 2019
|
Sigitova O.N., Kim T.Yu.
Immunoglobulin A nephropathy: clinical case with source in resistant remission
|
№2 / 2019
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|